Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Sep 1.

Published in final edited form as: Addict Behav. 2014 May 5;39(9):1325–1328. doi: 10.1016/j.addbeh.2014.04.020

Table 2.

Differences in HIV, HCV, and Coinfection Prevalence Within Race

N = 482

	White n=244 % (n)	p-value (X² test)	Black n=238 % (n)	p-value (X² test)
HIV+
Crack/Nasal	0% (0)		14% (22)
Heroin (n=211)
Heroin Injectors (n=106)	3% (2)	.307	15% (5)	.868
Polydrug	4% (5)		17% (9)
Injectors (n=165)
HCV+
Crack/Nasal	28% (15)		18% (29)
Heroin (n=211)
Heroin Injectors (n=106)	71% (52)	.001	79% (26)	.001
Polydrug	74% (87)		83% (39)
Injectors (n=165)
HCV and HIV
Crack/Nasal	0% (0)		4% (6)
Heroin (n=211)
Heroin Injectors (n=106)	3% (2)	.307	15% (5)	.004
Polydrug	4% (5)		17% (8)
Injectors (n=165)